These findings suggest that a decrease in the expression of SIK1 may be helpful to the disorders of glucolipid metabolism in diabetes, and certainly a method to overexpress SIK1 could lead to an efficient therapy for T2DM. Here, SIK1 is linked to type 2 diabetes mellitus.